Third Harmonic Bio, Inc.(THRD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

THRD Third Harmonic Bio, Inc.

Market Closed 04-17 16:00:00 EDT

5.16

+0.03

+0.58%

盘后5.16

+0.000.00%

16:07 EDT

High5.17	Low5.11	Vol525.91K
Open5.13	D1 Closing5.13	Amplitude1.27%
Mkt Cap232.74M	Tradable Cap67.21M	Total Shares45.10M
T/O2.70M	T/O Rate4.04%	Tradable Shares13.02M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"THRD","market":"US","secType":"STK","nameCN":"Third Harmonic Bio, Inc.","latestPrice":5.16,"timestamp":1744920000000,"preClose":5.13,"halted":0,"volume":525910,"hourTrading":{"tag":"盘后","latestPrice":5.16,"preClose":5.16,"latestTime":"16:07 EDT","volume":8889,"amount":45867.24,"timestamp":1744920471937},"delay":0,"floatShares":13024756,"shares":45103899,"eps":-1.089587,"marketStatus":"Market Closed","change":0.03,"latestTime":"04-17 16:00:00 EDT","open":5.13,"high":5.17,"low":5.105,"amount":2699381.168772,"amplitude":0.012671,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.089587,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1663214400000,"exchange":"NASDAQ","adjPreClose":5.13,"preHourTrading":{"tag":"盘前","latestPrice":5.15,"preClose":5.13,"latestTime":"08:54 EDT","volume":24,"amount":122.854896,"timestamp":1744894444461},"postHourTrading":{"tag":"盘后","latestPrice":5.16,"preClose":5.16,"latestTime":"16:07 EDT","volume":8889,"amount":45867.24,"timestamp":1744920471937},"volumeRatio":0.15835811741039504,"impliedVol":0.0494,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/THRD","defaultTab":"news","newsList":[{"id":"2527428559","title":"Companies Like Third Harmonic Bio (NASDAQ:THRD) Are In A Position To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2527428559","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527428559?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 19:16","pubTimestamp":1744715776,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-thrd/third-harmonic-bio/news/companies-like-third-harmonic-bio-nasdaqthrd-are-in-a-positi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B3QW5Z07.USD","PSQ","TQQQ","MNQmain","LU2095319765.USD","LU2210150020.SGD","NVIW.SI",".IXIC","TSYW.SI","IE00BGHQF748.EUR","BK4588","SQQQ","USJW.SI","NQmain","BK4585","IE00BKPKM429.USD","THRD","BK4112","QID","LU2210149790.SGD","IE00B64PRP62.GBP","USAW.SI","BK4007","NDAQ","QLD"],"gpt_icon":1},{"id":"2527268163","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2527268163","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527268163?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 20:48","pubTimestamp":1744634935,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio (THRD) shares rose 40% in recent Monday premarket activity, after saying its board has approved a plan for the company's liquidation and dissolution and will seek stockholder approv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0256863811.USD","LU0957791311.USD","LU2065170008.USD","MACW.SI","LU0256863902.USD","IE0004445239.USD","LU1066053197.SGD","LU0553294199.USD","LU0868494617.USD","LU0314104364.USD","LU2357305700.SGD","LU0096362180.USD","LU0316494557.USD","LU1674673428.USD","LU1280957306.USD","SG9999014898.SGD","LU1814569148.SGD","LU2543165471.USD","BK4550","IE0009356076.USD","LU1582986359.USD","HK0000306685.HKD","LU0889565833.HKD","VERV","IE00BKVL7J92.USD","LU0672654240.SGD","LU2462157665.USD","SG9999014542.SGD","BK4007","IE000YTNTUN2.SGD","LU0345768740.USD","LU1267930730.SGD","LU0979878070.USD","LU2602419157.SGD","BK4592","LU1244550494.USD","PTN.AU","LU2191332357.HKD","THRD","LU0048584097.USD","BK4507","LU1261432733.SGD","IE00B19Z8X17.USD","SG9999014575.USD","SG9999017495.SGD","LU1699723380.USD","LU0345770308.USD","PTN","BP"],"gpt_icon":1},{"id":"2527155079","title":"Third Harmonic Seeks to Liquidate, Dissolve Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2527155079","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527155079?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 19:28","pubTimestamp":1744630117,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio  said Monday its board has approved a plan for the company's liquidation and dissolution and will seek stockholder approval for the plan at its annual meeting on June 5.Under the plan, the company will wind down its operations and distribute its remaining cash to stockholders. The initial distribution will be between about $246.6 million and $255.4 million, or about $5.13 and $5.33 per share, and is expected to follow the filing of the certificate of dissolution, expected in Q3, the company said.Third Harmonics said it expects that its existing capital resources, together with the anticipated net proceeds from the sale of certain clinical assets, will enable it to meet its remaining liabilities and obligations with sufficient reserves. The company estimates that the total distribution will be between $246.6 million and $259.8 million.The estimates do not include cash that may become available for distribution from the proceeds from any sales of its remaining assets a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4020","THRD","BK4007","HLIT"],"gpt_icon":0},{"id":"2527155886","title":"BRIEF-Third Harmonic Bio Announces Plan Of Liquidation And Dissolution","url":"https://stock-news.laohu8.com/highlight/detail?id=2527155886","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527155886?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 19:18","pubTimestamp":1744629532,"startTime":"0","endTime":"0","summary":"BRIEF-Third Harmonic Bio Announces Plan Of Liquidation And DissolutionApril 14  - Third Harmonic Bio Inc THRD.O:THIRD HARMONIC BIO INC - INITIAL DISTRIBUTION EXPECTED BETWEEN $246.6 MILLION AND $255.4 MILLION IN Q3 THIRD HARMONIC BIO ANNOUNCES PLAN OF LIQUIDATION AND DISSOLUTIONSource text: [ID:]Further company coverage: THRD.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL8N3QS0PA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","THRD"],"gpt_icon":0},{"id":"2527534521","title":"Third Harmonic Shares Surge on Liquidation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2527534521","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527534521?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 19:16","pubTimestamp":1744629360,"startTime":"0","endTime":"0","summary":"Shares of Third Harmonic surged on Monday after the company's board approved a liquidation plan that will pay out $5.13 to $5.33 per share.The stock was up 37% at $4.99 in premarket trading. Shares were trading for $11.52 this time a year ago.The developer of pharmaceutical products said before the bell that it will wind down operations and pay shareholders proceeds from the sales of its assets and intellectual property, including its THB335 program developing a treatment for chronic spontaneous urticaria.\"Our management team and board of directors together have completed an efficient review of our strategic alternatives for maximizing the value of our assets and have determined that returning cash to shareholders and selling our assets, including THB335, is the best path forward,\" Chief Executive Natalie Holles said.Third Harmonic said it would complete all Phase 2 readiness activities for THB335 by the middle of the year to maximize the value of the program.The initial proceeds distr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","THRD","HLIT","BK4020"],"gpt_icon":0},{"id":"2527130961","title":"Third Harmonic Bio announces plan of liquidation and dissolution","url":"https://stock-news.laohu8.com/highlight/detail?id=2527130961","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527130961?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 18:51","pubTimestamp":1744627874,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio (THRD) announced that the company’s board of directors, after considering opportunities to maximize stockholder value, has appro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/third-harmonic-bio-announces-plan-of-liquidation-and-dissolution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/third-harmonic-bio-announces-plan-of-liquidation-and-dissolution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THRD","HLIT","BK4020","BK4007"],"gpt_icon":0},{"id":"2527137926","title":"Third Harmonic Bio Announces Plan of Liquidation and Dissolution","url":"https://stock-news.laohu8.com/highlight/detail?id=2527137926","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527137926?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 18:45","pubTimestamp":1744627500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nTUA5HTPSN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THRD","BK4007"],"gpt_icon":0},{"id":"2527137925","title":"Third Harmonic Bio Inc - Initial Distribution Expected Between $246.6 Mln and $255.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2527137925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527137925?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 18:45","pubTimestamp":1744627500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nTUA5HTPSN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THRD","BK4007"],"gpt_icon":0},{"id":"2527154788","title":"Third Harmonic Bio Announces Plan of Liquidation and Dissolution","url":"https://stock-news.laohu8.com/highlight/detail?id=2527154788","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527154788?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 18:45","pubTimestamp":1744627500,"startTime":"0","endTime":"0","summary":"Board of Directors has approved plan to liquidate and intends to seek stockholder approval for dissolution of the Company at the Annual Meeting of Stockholders on June 5, 2025. Sale of the Company’s assets, including THB335, to be initiated pending stockholder approval of the Plan of Liquidation and Dissolution. On April 10, 2025, the Board of Directors unanimously approved the dissolution and liquidation of the Company, subject to stockholder approval, pursuant to the Plan of Dissolution. The Company intends to hold its annual meeting of stockholders on June 5, 2025, at which it will seek stockholder approval of the Plan of Dissolution. If the Company’s stockholders approve the Plan of Dissolution, the Company currently intends to file a Certificate of Dissolution, delist its shares of common stock from The Nasdaq Global Select Market, satisfy or resolve its remaining liabilities and obligations, including but not limited to contingent liabilities and claims and costs associated with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/third-harmonic-bio-announces-plan-104500334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["THRD","BK4007","HLIT","BK4020"],"gpt_icon":0},{"id":"2522082675","title":"Third Harmonic Bio Cut to Hold From Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2522082675","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522082675?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 22:04","pubTimestamp":1743170640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/THRD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 28, 2025 10:04 ET (14:04 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD","BK4020","BK4007","SF","HLIT","BK4127"],"gpt_icon":0},{"id":"2522049520","title":"Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2522049520","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522049520?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 19:39","pubTimestamp":1743161957,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio (THRD) has an average rating of Hold and mean price target of $4.63, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","THRD","HLIT"],"gpt_icon":0},{"id":"2522355309","title":"Third Harmonic Bio Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522355309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522355309?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 21:29","pubTimestamp":1743082198,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio Inc reports results for the quarter ended December 31 - Earnings SummaryThird Harmonic Bio Inc THRD.OQ reported a quarterly adjusted loss of 48 cents per share for the quarter ended","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA18T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD"],"gpt_icon":0},{"id":"2522537724","title":"Third Harmonic Bio FY 2024 GAAP EPS $(1.09) Beats $(1.18) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522537724","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522537724?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 20:23","pubTimestamp":1743078187,"startTime":"0","endTime":"0","summary":"Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.18) by 7.63 percent. This is a 39.74 percent decrease over losses of $(0.78) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44512541/third-harmonic-bio-fy-2024-gaap-eps-1-09-beats-1-18-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD","HLIT"],"gpt_icon":0},{"id":"2522377284","title":"BRIEF-Third Harmonic Bio Q4 Net Income USD -13.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522377284","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522377284?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 20:20","pubTimestamp":1743078043,"startTime":"0","endTime":"0","summary":"BRIEF-Third Harmonic Bio Q4 Net Income USD -13.1 MillionMarch 27 (Reuters) - Third Harmonic Bio Inc THRD.O:THIRD HARMONIC BIO Q4 NET INCOME USD -13.1 MILLIONSource text: ID:nGNX7FfSrqFurther company coverage: THRD.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX455F5C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","THRD"],"gpt_icon":0},{"id":"2522784377","title":"Third Harmonic Bio initiates process to identify opportunities to maximize value","url":"https://stock-news.laohu8.com/highlight/detail?id=2522784377","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522784377?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 20:15","pubTimestamp":1743077739,"startTime":"0","endTime":"0","summary":"In parallel with THB335 Phase 2 readiness activities, Third Harmonic Bio (THRD) has initiated a process to identify opportunities to maximize share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/third-harmonic-bio-initiates-process-to-identify-opportunities-to-maximize-value?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/third-harmonic-bio-initiates-process-to-identify-opportunities-to-maximize-value?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THRD","BK4020","BK4007","HLIT"],"gpt_icon":0},{"id":"2522372740","title":"Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522372740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522372740?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 20:10","pubTimestamp":1743077400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA9JN5LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THRD","BK4007"],"gpt_icon":0},{"id":"2522372721","title":"Third Harmonic Bio Inc - Strategic Alternatives Process Underway to Maximize Value Creation","url":"https://stock-news.laohu8.com/highlight/detail?id=2522372721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522372721?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 20:10","pubTimestamp":1743077400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA9JN5LR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THRD","BK4007"],"gpt_icon":0},{"id":"2522727293","title":"Third Harmonic Bio Q4 Net Income USD -13.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522727293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522727293?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 20:10","pubTimestamp":1743077400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX455F5C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","THRD"],"gpt_icon":0},{"id":"2522537222","title":"Press Release: Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522537222","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522537222?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 20:10","pubTimestamp":1743077400,"startTime":"0","endTime":"0","summary":"Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria . Strategic alternatives process underway to maximize value creation across all assets in the company. Strong financial position with cash and cash equivalents totaling $285.1 million. SAN FRANCISCO, March 27, 2025  -- Third Harmonic Bio, Inc. , a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today reported financial results for the fourth quarter and full year ended December 31, 2024.In February 2025, the Company halted all non-THB335 related research and discovery activities and undertook a reduction in workforce of approximately 50%.Cash Position: Cash and cash equivalents totaled $285.1 million as of December 31, 2024. Based on the Company's current operating plan, and subject to its strategic review process, Third Harmonic Bio believes that its existing cash and cash equivalents will be sufficient to fund its ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRD","HLIT","BK4020","BK4007"],"gpt_icon":0},{"id":"2521714099","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714099?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 18:00","pubTimestamp":1742810400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Comp de San Bas                                  4Q       .36       AMC. ·Oklo Inc. Class A                               4Q      (.07)      AMC. ·Core & Main Inc.                                 4Q       .36       BMO. ·McCormick & Co                                 1Q       .64   6:30 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH","PDSB","LPTX","SDST","TEN","MLKN","ABL","ALUR","CHWY","CLSD","GRDN","XFOR","DERM","FBIO","IVA","RLMD","SKYX","CDLR","AFMD","WGO","ZURA","IOBT","SLRN","CALC","PAYS","BEEM","ANTX","PAYX","KBH","MDAI","KOD","EDAP","UNCY","BCAB","THRD","IKT","MREO","CRMD","MKC","WOOF","WBA","ACRV","NUTX","DLTR","GOVX","SURG","CTAS","CNXC","OBIO","SCS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.thirdharmonicbio.com","stockEarnings":[{"period":"1week","weight":0.487},{"period":"1month","weight":0.4743},{"period":"3month","weight":-0.1088},{"period":"6month","weight":-0.6166},{"period":"1year","weight":-0.5426},{"period":"ytd","weight":-0.4985}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.","exchange":"NASDAQ","name":"Third Harmonic Bio, Inc.","nameEN":"Third Harmonic Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Third Harmonic Bio, Inc.(THRD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Third Harmonic Bio, Inc.(THRD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Third Harmonic Bio, Inc.,THRD,Third Harmonic Bio, Inc.股票,Third Harmonic Bio, Inc.股票老虎,Third Harmonic Bio, Inc.股票老虎国际,Third Harmonic Bio, Inc.行情,Third Harmonic Bio, Inc.股票行情,Third Harmonic Bio, Inc.股价,Third Harmonic Bio, Inc.股市,Third Harmonic Bio, Inc.股票价格,Third Harmonic Bio, Inc.股票交易,Third Harmonic Bio, Inc.股票购买,Third Harmonic Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Third Harmonic Bio, Inc.(THRD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Third Harmonic Bio, Inc.(THRD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction